Daniel Rea
University Hospitals Birmingham NHS Foundation Trust(GB)Queen Elizabeth Hospital Birmingham(GB)Cancer Research UK Clinical Trials Unit(GB)University of Birmingham(GB)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Estrogen and related hormone effects, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology
Most-Cited Works
- → Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With Advanced Solid Tumors(2008)476 cited
- → aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.(2013)446 cited
- → Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas(2005)421 cited
- → Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial(2011)375 cited
- → Addressing overtreatment of screen detected DCIS; the LORIS trial(2015)369 cited
- → Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial(2020)340 cited